Immunic, Inc. Shareholders' Equity
Immunic, Inc. (IMUX) had Shareholders' Equity of $127.58 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-11
- 2026-06-30: Stockholders' Equity Attributable to Parent $127.58M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $151.23M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$6.67M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $10.50M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $127.58M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $151.23M 10-Q · filed 2026-08-11 | |
| 2025-12-31 | -$6.67M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $10.50M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $33.91M 10-Q · filed 2026-08-11 | |
| 2025-03-31 | -$5.29M 10-Q · filed 2026-08-11 | |
| 2024-12-31 | $18.43M 10-Q · filed 2026-08-11 | |
| 2024-09-30 | $41.22M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $63.57M 10-Q · filed 2025-11-13 | |
| 2024-03-31 | $83.58M 10-Q · filed 2025-11-13 | |
| 2023-12-31 | $28.93M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $48.41M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $69.28M 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $91.22M 10-Q · filed 2024-11-07 | |
| 2022-12-31 | $113.68M 10-K · filed 2025-03-31 | |
| 2022-09-30 | $108.81M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $127.85M 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $137.96M 10-Q · filed 2023-11-14 | |
| 2021-12-31 | $127.11M 10-K · filed 2024-02-22 | |
| 2021-09-30 | $145.47M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $120.74M 10-Q · filed 2022-11-03 | |
| 2021-03-31 | $137.45M 10-Q · filed 2022-11-03 | |
| 2020-12-31 | $158.78M 10-K · filed 2023-02-23 | |
| 2020-09-30 | $162.88M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $78.69M 10-Q · filed 2021-11-04 | |
| 2020-03-31 | $50.49M 10-Q · filed 2021-11-04 | |
| 2019-12-31 | $58.36M 10-K · filed 2022-02-24 | |
| 2019-09-30 | $60.53M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $69.41M 10-Q · filed 2020-11-06 | |
| 2019-03-31 | -$9.77M 10-Q · filed 2020-11-06 | $9.05M 10-Q · filed 2019-04-10 |
| 2018-12-31 | -$25.74M 10-K · filed 2021-02-26 | $12.43M 10-K · filed 2019-03-04 |
| 2018-09-30 | -$20.80M 10-Q · filed 2019-11-07 | $14.25M 10-Q · filed 2018-11-08 |
| 2018-06-30 | -$18.97M 10-Q · filed 2019-11-07 | $26.45M 10-Q · filed 2018-08-07 |
| 2018-03-31 | -$15.57M 10-Q · filed 2019-08-08 | $37.30M 10-Q · filed 2018-05-08 |
| 2017-12-31 | -$13.34M 10-K · filed 2020-03-16 | $50.04M 10-K · filed 2018-03-13 |
| 2017-09-30 | $62.08M 10-Q · filed 2017-10-25 | |
| 2017-06-30 | $73.34M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $84.43M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $58.45M 10-K · filed 2019-03-04 | |
| 2016-09-30 | $67.76M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $74.15M 10-Q · filed 2016-08-02 | |
| 2016-03-31 | $78.05M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $82.33M 10-K · filed 2019-03-04 | |
| 2015-09-30 | $58.68M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $69.74M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $83.78M 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $97.56M 10-K · filed 2018-03-13 | |
| 2014-09-30 | $77.05M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $89.16M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | -$58.02M 10-Q · filed 2014-05-28 | |
| 2013-12-31 | -$44.66M 10-K · filed 2017-03-07 | |
| 2012-12-31 | -$7.63M 10-K · filed 2016-03-08 | |
| 2011-12-31 | -$54.85M 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B |